S'abonner

Treatment of suspected sepsis and septic shock in children with chronic disease seen in the pediatric emergency department - 28/05/21

Doi : 10.1016/j.ajem.2021.01.026 
Emily Hegamyer , Nadine Smith , Amy D. Thompson , Andrew D. Depiero
 Division of Emergency Medicine, Department of Pediatrics, Nemours, Alfred I. Dupont Hospital for Children. 1600 Rockland Road, Wilmington, DE 19803, United States of America 

Corresponding author.

Abstract

Background

Research demonstrates that timely recognition and treatment of sepsis can significantly improve pediatric patient outcomes, especially regarding time to intravenous fluid (IVF) and antibiotic administration. Further research suggests that underlying chronic disease in a septic pediatric patient puts them at higher risk for poor outcomes.

Objective

To compare treatment time for suspected sepsis and septic shock in pediatric patients with chronic disease versus those without chronic disease seen in the Pediatric Emergency Department (PED).

Methods

We reviewed patient data from a pediatric sepsis outcomes dataset collected at two tertiary care pediatric hospital sites from January 2017–December 2018. Patients were stratified into two groups: those with and without chronic disease, defined as any patient with at least one of eight chronic health conditions. Inclusion criteria: patients seen in the PED ultimately diagnosed with sepsis or septic shock, patient age 0 to 20 years and time zero for identification of sepsis in the PED. Exclusion criteria: time zero unavailable, inability to determine time of first IVF or antibiotic administration or patient death within the PED. Primary analysis included comparison of time zero to first IVF and antibiotic administration between each group.

Results

312 patients met inclusion criteria. 169 individuals had chronic disease and 143 did not. Median time to antibiotics in those with chronic disease was 41.9 min versus 43.0 min in patients without chronic disease (p = 0.181). Time to first IVF in those with chronic disease was 22.0 min versus 12.0 min in those without (p = 0.010). Those with an indwelling line/catheter (n = 40) received IVF slower than those without (n = 272), with no significant difference in time to antibiotic administration by indwelling catheter status (p = 0.063). There were no significant differences in the mode of identification of suspected sepsis or septic shock between those with versus without chronic disease (p = 0.27).

Conclusions

Study findings suggest pediatric patients with chronic disease with suspected sepsis or septic shock in the PED have a slower time to IVF administration but equivocal use of sepsis recognition tools compared to patients without chronic disease.

Le texte complet de cet article est disponible en PDF.

Highlights

Median time to first IVF bolus from time of sepsis recognition is significantly longer in pediatric patients with chronic disease presenting to the PED
No significant differences in time to first IVF bolus or antibiotic administration from time of sepsis recognition in those pediatric patients with versus without an indwelling catheter presenting to the PED
No significant differences in mode of identification for suspected sepsis or septic shock in those with versus without chronic disease presenting to the PED

Le texte complet de cet article est disponible en PDF.

Keywords : Sepsis, Pediatric, Chronic disease, Intravenous access, Antimicrobial therapy, Fluid resuscitation


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 44

P. 56-61 - juin 2021 Retour au numéro
Article précédent Article précédent
  • NLR and CRP to albumin ratio as a predictor of in-hospital mortality in the geriatric ED patients
  • Mustafa Kür?at Ayranc?, Kadir Küçükceran, Zerrin Defne Dundar
| Article suivant Article suivant
  • Regional variation in outcomes and healthcare resources utilization in, emergency department visits for syncope
  • Waseem Khaliq, Moeen Aboabdo, Che Matthew Harris, Noor Bazerbashi, Eric Moughames, Nour Al Jalbout, Karim Hajjar, Hind A. Beydoun, May A. Beydoun, Shaker M. Eid

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.